MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET EBITDA Margin
EBITDA as a percentage of revenue.
MetLife, Inc.NYSE: MET
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin holds steady near 7.0%
EBITDA Margin was 7.0% in Q2 FY2026, down 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 7.6%, down 1.8 pp year over year. Over 3 fiscal years it narrowed by 3.3 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 11.4% for the fiscal year ending Dec 2026, up from 8.4% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 7.0%-2.3 pp QoQ
- Last fiscal yearDec 2025
- 8.4%-2.1 pp YoY
- LTMJun 2026
- 7.6%-1.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.2 pp | +3.2 pp | +3.4 pp |
| 1 year | -2.1 pp | +3.0 pp | +5.2 pp |
| 3 years | -3.3 pp | +4.1 pp | +7.4 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 8.4%
- Year-over-year change
- -2.1pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.4% | -2.1pp |
| FY2024 | 2024-12-31 | 10.5% | +4.7pp |
| FY2023 | 2023-12-31 | 5.8% | -5.9pp |
| FY2022 | 2022-12-31 | 11.7% | -4.3pp |
| FY2021 | 2021-12-31 | 16.0% | — |
EBITDA Margin vs competitors
How MET compares with its peers on the latest reported figures
- MET's LTM Jun 2026 EBITDA Margin of 7.6% is the lowest of the 11 companies compared; the peer median is 16.9%.
- Its year-over-year change of -1.8 pp is the 7th highest of 11, against a peer median of -0.8 pp.
- Over three fiscal years its change of -3.3 pp compares with a peer median of -0.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 39.3% | +19.6 pp | +6.5 pp | |
| LTM Jun 2026 | 25.2% | -0.0 pp | -6.8 pp | |
| LTM Sep 2026 | 22.7% | -8.0 pp | +2.2 pp | |
| LTM Jun 2026 | 19.4% | -1.5 pp | -14.8 pp | |
| LTM Sep 2026 | 17.4% | -4.8 pp | -63.6 pp | |
| LTM Jun 2026 | 16.3% | +7.8 pp | -2.4 pp | |
| LTM Jun 2026 | 16.1% | +5.2 pp | +32.6 pp | |
| LTM Jun 2026 | 9.5% | -8.0 pp | -7.6 pp | |
| LTM Sep 2026 | 9.5% | -16.8 pp | +3.7 pp | |
| LTM Jun 2026 | 8.1% | +4.1 pp | +11.0 pp | |
| LTM Jun 2026 | 7.6% | -1.8 pp | -3.3 pp | |
| Peer median (excluding MET) | 16.9% | -0.8 pp | -0.1 pp | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.